@pharm3rtx@iah From inside security you can walk between C or E (not that far) or take the Sky Train. From outside security you can take the basement train.
@Aiims1742 This is extremely sad as research on Pancreatic cancer is just now yielding tangible benefits for patients suffering from this deadliest of cancers. Very little PDAC research is funded by NCI, PanCAN hasn't been able to fund research grants since 2023 - this really hurts :(
@bparkerkerrigan@Lindonlight@MDAndersonNews@ImmunoGenesis_ We are so grateful to Lindonlight for giving us the ability to take this STING agonist based therapy that generated complete responses against Gliomas in both mice and pet dogs into the clinic. We hope to be able to help patients suffering with both adult and childhood GBM 🙏.
@Lindonlight is honored to have contributed 2M to @MDAndersonNews‘s Dr. Michael Curran @drcurran and the entire @ImmunoGenesis_ team in their quest for a cure for brain cancer.
More on their exciting research can be found here: https://t.co/Eo5ErKi07X
Dr. James Allison, Nobel Prize winner in Physiology or Medicine, is taking time out today to teach a new generation of trainees about T cell checkpoint blockade in the SITC Primer on Tumor Immunology and Cancer Immunotherapy! #SITC2020#ScienceHero
Director of our Scientific Advisory Council Dr. James P. Allison of @MDAndersonNews was once called "foolish" for claiming that the immune system could fight off #cancer. https://t.co/m5sQ3lVHy4
https://t.co/sw4CqbS27H finally published in final form today describing how hypoxia keeps T cells out of prostate cancer, and how the drug Evofosfamide can be used to restore normoxia and, with it, sensitivity to immunotherapy. Commentary: https://t.co/hA7NDxpX5s
Congratulations to Jim Allison who won the 2018 Nobel Prize for Medicine today! Cancer has never known a greater foe and I have never known a more determined and rigorous scientist and inspiring mentor. #Immunotherapy#NobelMedicinePrize #@MDAndersonNews